4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001610717-26-000002
Chief Financial Officer sold 6,552 shares at $23.38 ($153,186)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goeltz II Robert C. Chief Financial Officer | 2025-12-31 | Sale 10b5-1 | −6,552 | $23.38 | $153,186 | 67,924 | D: show line 1 in the form |
| Open-market sales · 6,552 sh · avg $23.38 · $153,186 | |||||||
Loading xslF345X05/form4.xml…